Research progress on the protective effects of aucubin in neurological diseases

• Published in: Pharmaceutical biology 2022-12, Vol.60 (1), p.1088-1094
• Main Authors: Yang, Ping, Zhang, Qiaoyue, Shen, Hengyan, Bai, Xinyu, Liu, Ping, Zhang, Tao
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; Apoptosis; Autophagy; Cell differentiation; Clinical trials; Diabetes mellitus; Encephalopathy; Epilepsy; Eucommia ulmoides Oliv; Eucommiaceae - chemistry; Hemorrhage; Humans; Inflammation; Iridoid Glucosides - pharmacology; Iridoids; molecular mechanism; Movement disorders; Neural Stem Cells; Neurodegenerative diseases; Neurological diseases; Parkinson's disease; Pharmacological effects; Review; Synapses; Traditional Chinese medicine; Traumatic brain injury; γ-Aminobutyric acid
• ISSN: 1388-0209; 1744-5116
• DOI: 10.1080/13880209.2022.2074057

Aucubin (AU), an iridoid glycoside that is one of the active constituents of Eucommia ulmoides Oliv. (EUO) (Eucommiaceae), a traditional Chinese medicine, has been extensively studied in the management of neurological diseases (NDs). However, a comprehensive review of its effects and mechanisms in this regard is currently not available. To compile the protective effects and mechanisms of AU in NDs and provide a basis for further research. We used 'aucubin' as the 'All Fields' or 'MeSH' in PubMed, Web of Science and China National Knowledge Infrastructure without any limitation to search all relevant articles as comprehensively as possible; we selected the articles on AU treatment of NDs for summary. Studies reviewed herein reported that AU improved the symptoms or prognosis of Parkinson's disease, Alzheimer's disease, intracerebral haemorrhage, diabetic encephalopathy, epilepsy, anxiety and depression, and traumatic brain injury. The pharmacological mechanisms involved in repairing neuronal loss were postulated to include increasing γ-aminobutyric acid (GABA) content in the synapse, promoting differentiation of neural precursor cells into GABAergic neurons, providing antioxidant and anti-neuroinflammation activities, as well as enhancing autophagy and anti-apoptotic actions. The protective effects of AU on some NDs have been confirmed. According to the pharmacological effects, AU is also highly likely to have protective effects on other NDs, which can be realized by further in vivo and in vitro basic research, and clinical trials. In the future, AU may be used for clinical prevention or treatment of patients with neurological diseases.